Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection

Por Dash, Prasanta K, Siddappa, Nagadenahalli B, Mangaiarkarasi, Asokan, Mahendarkar, Aruna V, Roshan, Padmanabhan, Anand, Krishnamurthy Kumar, Mahadevan, Anita, Satishchandra, Parthasarathy, Shankar, Susarla K, Prasad, Vinayaka R, Ranga, Udaykumar
Publicado em 2008

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention

Por Young D. Kwon, Mangaiarkarasi Asokan, Jason Gorman, Baoshan Zhang, Qingbo Liu, Mark K. Louder, Bob C. Lin, Krisha McKee, Amarendra Pegu, Raffaello Verardi, Eun Sung Yang, VRC Production Program, Kevin Carlton, Nicole A. Doria-Rose, Paolo Lusso, John R. Mascola, Peter D. Kwong
Publicado em 2021-01-01

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

Por Gwo-Yu Chuang, Mangaiarkarasi Asokan, Vera B. Ivleva, Amarendra Pegu, Eun Sung Yang, Baoshan Zhang, Rajoshi Chaudhuri, Hui Geng, Bob C. Lin, Mark K. Louder, Krisha McKee, Sijy O’Dell, Hairong Wang, Tongqing Zhou, Nicole A. Doria-Rose, Lisa A. Kueltzo, Q. Paula Lei, John R. Mascola, Peter D. Kwong
Publicado em 2020-01-01